JP2011525914A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525914A5
JP2011525914A5 JP2011516244A JP2011516244A JP2011525914A5 JP 2011525914 A5 JP2011525914 A5 JP 2011525914A5 JP 2011516244 A JP2011516244 A JP 2011516244A JP 2011516244 A JP2011516244 A JP 2011516244A JP 2011525914 A5 JP2011525914 A5 JP 2011525914A5
Authority
JP
Japan
Prior art keywords
seq
tetradecapeptide
somatostatin
nucleic acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011516244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525914A (ja
JP5506792B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/068195 external-priority patent/WO2009157926A1/en
Publication of JP2011525914A publication Critical patent/JP2011525914A/ja
Publication of JP2011525914A5 publication Critical patent/JP2011525914A5/ja
Application granted granted Critical
Publication of JP5506792B2 publication Critical patent/JP5506792B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011516244A 2008-06-25 2008-06-25 クロラムフェニコールアセチルトランスフェラーゼ(cat)不完全ソマトスタチン融合タンパク質およびその使用 Expired - Fee Related JP5506792B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/068195 WO2009157926A1 (en) 2008-06-25 2008-06-25 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof

Publications (3)

Publication Number Publication Date
JP2011525914A JP2011525914A (ja) 2011-09-29
JP2011525914A5 true JP2011525914A5 (enExample) 2012-07-12
JP5506792B2 JP5506792B2 (ja) 2014-05-28

Family

ID=41444809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011516244A Expired - Fee Related JP5506792B2 (ja) 2008-06-25 2008-06-25 クロラムフェニコールアセチルトランスフェラーゼ(cat)不完全ソマトスタチン融合タンパク質およびその使用

Country Status (15)

Country Link
US (3) US7722881B2 (enExample)
EP (1) EP2303314B1 (enExample)
JP (1) JP5506792B2 (enExample)
KR (1) KR101555731B1 (enExample)
CN (1) CN102105163B (enExample)
AU (1) AU2008358353B2 (enExample)
CA (1) CA2728734A1 (enExample)
DK (1) DK2303314T3 (enExample)
ES (1) ES2445403T3 (enExample)
IL (1) IL209792A (enExample)
MX (1) MX2010014082A (enExample)
NZ (1) NZ590011A (enExample)
RU (1) RU2501565C2 (enExample)
WO (1) WO2009157926A1 (enExample)
ZA (1) ZA201009125B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2728735A1 (en) 2008-06-25 2009-12-30 Braasch Biotech Llc Compositions and methods for enhanced somatostatin immunogenicity
RU2501565C2 (ru) 2008-06-25 2013-12-20 Брааш Биотех Ллк Слитый белок дефектная хлорамфеникол ацетилтрансфераза (сат)-соматостатин и его применения
WO2014003538A1 (en) * 2012-06-26 2014-01-03 Biovalence Sdn. Bhd. Rapid specific pathogen free animal
JP6595340B2 (ja) 2012-11-08 2019-10-23 ペアシュイ ファルマ ソシエテ アノニム C4sプロテオグリカン特異的トランスポーター分子
RU2526571C1 (ru) * 2013-04-08 2014-08-27 Сергей Михайлович Юдин Инъекционный препарат для повышения спермопродукции человека и способ его применения
WO2016029013A2 (en) 2014-08-21 2016-02-25 Braasch Biotech Llc Methods for improving immunological response in vaccinated animals
WO2021024020A1 (en) 2019-08-06 2021-02-11 Astellas Pharma Inc. Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer
JP7727389B2 (ja) * 2020-02-11 2025-08-21 ブラッシュ・バイオテック・エルエルシー 乳房炎の処置及び/又は予防のための組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342832A (en) 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4446235A (en) 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
WO1989004326A1 (en) * 1987-11-04 1989-05-18 California Biotechnology Inc. Alveolar surfactant proteins
US6316004B1 (en) * 1993-06-22 2001-11-13 T. Tikhonenko Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
RU2034457C1 (ru) * 1993-06-22 1995-05-10 Товарищество с ограниченной ответственностью "Ветек" Способ повышения продуктивности сельскохозяйственных животных и препарат для его осуществления
US6025368A (en) 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US20070048860A1 (en) 1997-10-10 2007-03-01 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Carcinoembryonic antigen (CEA) peptides
PL213561B1 (pl) * 2004-01-09 2013-03-29 Inst Biotechnologii I Antybiotykow Sposób otrzymywania plazmidu, plazmid oraz zastosowania
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
EP1896002A4 (en) 2005-06-27 2009-11-25 Biovail Lab Int Srl BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
CA2728735A1 (en) 2008-06-25 2009-12-30 Braasch Biotech Llc Compositions and methods for enhanced somatostatin immunogenicity
RU2501565C2 (ru) 2008-06-25 2013-12-20 Брааш Биотех Ллк Слитый белок дефектная хлорамфеникол ацетилтрансфераза (сат)-соматостатин и его применения

Similar Documents

Publication Publication Date Title
JP2011525914A5 (enExample)
JP2009268467A5 (enExample)
JP2006149395A5 (enExample)
JP2008529558A5 (enExample)
JP2012095652A5 (enExample)
JP2023082054A5 (enExample)
JP2008538183A5 (enExample)
JP2006187292A5 (enExample)
JP2008536483A5 (enExample)
JP2006516098A5 (enExample)
JP2007075118A5 (enExample)
JP2011004753A5 (enExample)
JP2010534684A5 (enExample)
JP2012515557A5 (enExample)
ZA200708407B (en) IL-21 variants
JP2004531242A5 (enExample)
JP2008525033A5 (enExample)
JP2010088434A5 (enExample)
WO2009024327A3 (en) New proteins for use in human and animal staphylococcus infections
JP2015514132A5 (enExample)
JP2015522264A5 (enExample)
JP2010142226A5 (enExample)
JP2010532656A5 (enExample)
JP2010265269A5 (enExample)
JP2008541776A5 (enExample)